Senicapoc trial results support the existence of different sub-phenotypes of sickle cell disease with possible drug-induced phenotypic shifts

Br J Haematol. 2011 Dec;155(5):636-8. doi: 10.1111/j.1365-2141.2011.08758.x. Epub 2011 Jul 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetamides / adverse effects*
  • Acetamides / therapeutic use*
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / classification*
  • Anemia, Sickle Cell / drug therapy*
  • Hemoglobin, Sickle / metabolism
  • Humans
  • Pain / chemically induced
  • Phenotype
  • Randomized Controlled Trials as Topic
  • Triphenylmethyl Compounds / adverse effects*
  • Triphenylmethyl Compounds / therapeutic use*

Substances

  • Acetamides
  • Hemoglobin, Sickle
  • Triphenylmethyl Compounds
  • senicapoc